GWLL

GOLDENWELL BIOTECH, INC.

Company Overview

Goldenwell Biotech, Inc., focuses on nutraceutical and dietary supplements business in the United States. It is developing JI MAI, a bovine cardiac vascular active peptide; Double Proline AG, a 3D active collagen peptide drinkable cosmetic; Cartilage Peptide, a Type II collagen peptide; and Sugar Master, a dietary supplement. The company was incorporated in 2019 and is based in Hudson, Ohio.

SectorHealthcare
IndustryMedical - Pharmaceuticals
Market Cap$69.3M
Employees3
CEOShuang Liu

Valuation

Current Price$0.7
Fair Value?$000.00
Valuation?No valuation
Hist. PE ?N/A
EPS (TTM) ?0
Forward EPS Growth ?
Historical Growth ?-31.84%
Equity, FCF, Long Term Debt, Net Profit, and Shares Outstanding history charts are available on the Pro plan for just $9.99/month.Sign in to unlock Pro

Price

EPS

Revenue

Equity

Pro

Available on the Pro plan

Free Cash Flow

Pro

Available on the Pro plan

Long Term Debt

Pro

Available on the Pro plan

Net Profit

Pro

Available on the Pro plan

Shares Outstanding

Pro

Available on the Pro plan

Last updated: 9/5/2026, 6:19:58 PM